Completed
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease
NCT03257046
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Atlanta Center for Medical Research Atlanta, Georgia, United States
- Duke Early Phase Research Unit Durham, North Carolina, United States